MENU
+Compare
NUVB
Stock ticker: NYSE
AS OF
Dec 3, 04:59 PM (EDT)
Price
$8.37
Change
+$0.90 (+12.05%)
Capitalization
2.7B

NUVB Nuvation Bio Forecast, Technical & Fundamental Analysis

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates... Show more

NUVB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NUVB with price predictions
Nov 28, 2025

Aroon Indicator for NUVB shows an upward move is likely

NUVB's Aroon Indicator triggered a bullish signal on November 25, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 161 similar instances where the Aroon Indicator showed a similar pattern. In of the 161 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 19, 2025. You may want to consider a long position or call options on NUVB as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NUVB just turned positive on November 19, 2025. Looking at past instances where NUVB's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NUVB advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUVB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NUVB broke above its upper Bollinger Band on November 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NUVB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.292) is normal, around the industry mean (27.312). P/E Ratio (0.000) is within average values for comparable stocks, (52.442). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.886). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (100.000) is also within normal values, averaging (321.020).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUVB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
NUVB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NUVB is expected to report earnings to fall 35.44% to -10 cents per share on March 05

Nuvation Bio NUVB Stock Earnings Reports
Q4'25
Est.
$-0.10
Q3'25
Beat
by $0.01
Q2'25
Est.
$-0.17
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.01
The last earnings report on November 03 showed earnings per share of -15 cents, beating the estimate of -17 cents. With 3.48M shares outstanding, the current market capitalization sits at 2.70B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1500 Broadway
Phone
+1 332 208-6102
Employees
51
Web
https://www.nuvationbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTWRX19.72N/A
N/A
Templeton World R6
VEXPX123.07N/A
N/A
Vanguard Explorer Inv
MIRSX23.33N/A
N/A
Victory Integrity Small/Mid-Cap Value R6
REIFX14.25N/A
N/A
Third Avenue International RE Val Fndrs
HFDRX19.87N/A
N/A
Hartford Schroders US MidCap Opps R3

NUVB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with FULC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then FULC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
-5.20%
FULC - NUVB
45%
Loosely correlated
-9.27%
NRIX - NUVB
44%
Loosely correlated
-3.31%
IPSC - NUVB
41%
Loosely correlated
-2.62%
RCUS - NUVB
41%
Loosely correlated
-2.49%
VCYT - NUVB
40%
Loosely correlated
-0.43%
More